Sea Crest Wealth Management, LLC Arvinas, Inc. Transaction History

Sea Crest Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$36.01 - $74.24 $48,613 - $100,224	1,350 New	1,350 $57,000
Q4 2021 Feb 11, 2022	SELL	$65.85 - $96.21 $176,477 - $257,842	-2,680 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$73.2 - $107.87 $60,390 - $88,992	-825 Reduced 23.54%	2,680 $220,000
Q2 2021 Aug 12, 2021	BUY	$60.45 - $84.26 $211,877 - $295,331	3,505 New	3,505 $270,000
Q2 2019 Jul 19, 2019	SELL	$15.96 - $23.8 $20,748 - $30,940	-1,300 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$13.55 - $23.79 $13,550 - $23,790	1,000 Added 333.33%	1,300 $19,000
Q3 2018 Nov 14, 2018	BUY	$16.05 - $16.87 $4,815 - $5,061	300 New	300 $5,000

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.